Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
- 4 September 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 96 (1), 105-110
- https://doi.org/10.1016/0304-3835(95)03919-n
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promotersCancer Letters, 1995
- Apoptosis as a goal of cancer therapyCurrent Opinion in Oncology, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Apoptosis and p53 protein expression in human hepatoma cells induced by etoposide, mitomycin C and thapsigarginInternational Hepatology Communications, 1994
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Retroviral Transfer of Herpes Simplex Thymidine Kinase Gene into Glioma Cells Causes Targeting of Gancyclovir Cytotoxic EffectNeurologia medico-chirurgica, 1994
- Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir. National Institutes of HealthHuman Gene Therapy, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Programmed cell death: Apoptosis and oncogenesisCell, 1991
- Construction and applications of a highly transmissible murine retrovirus shuttle vectorCell, 1984